Given the apparent high false positive CTCs identified by ISET-morphology, a similar but non-comparable ERα-based multiplex immunocytochemistry staining assay was employed with the aim of increasing specificity of CTC identification in ER positive breast cancer patients. This evidence concerns the gene ESR1 and breast carcinoma.